BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev 2018;70:197-245. [PMID: 29487083 DOI: 10.1124/pr.117.014381] [Cited by in Crossref: 89] [Cited by in F6Publishing: 57] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Tang D, Ma J, Sun S. Auditory Neural Plasticity in Tinnitus Mechanisms and Management. Neural Plast 2020;2020:7438461. [PMID: 32684922 DOI: 10.1155/2020/7438461] [Reference Citation Analysis]
2 Guo R, Shi AM, Deng L, Li L, Wang LC, Oteng AB, Wei MP, Zhao ZH, Hooiveld G, Zhang C, Wang Q. Flavonoid-Like Components of Peanut Stem and Leaf Extract Promote Sleep by Decreasing Neuronal Excitability. Mol Nutr Food Res 2021;:e2100210. [PMID: 34747100 DOI: 10.1002/mnfr.202100210] [Reference Citation Analysis]
3 Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF. The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial. Neuropsychopharmacology 2021. [PMID: 34635802 DOI: 10.1038/s41386-021-01191-3] [Reference Citation Analysis]
4 Exposto FG, Arima T, Svensson P. Sleep Disorders and Chronic Orofacial Pain. Curr Sleep Medicine Rep 2019;5:104-11. [DOI: 10.1007/s40675-019-00152-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Wang X, Huang Y, Li M, Lin H, Lin C, Yang W, Ye X. Acupoint catgut embedding for insomnia: Protocol for a systematic review and data mining. Medicine (Baltimore) 2020;99:e19333. [PMID: 32118766 DOI: 10.1097/MD.0000000000019333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Saunders DP, Rouleau T, Cheng K, Yarom N, Kandwal A, Joy J, Bektas Kayhan K, van de Wetering M, Brito-Dellan N, Kataoka T, Chiang K, Ranna V, Vaddi A, Epstein J, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 2020;28:2473-84. [PMID: 32052137 DOI: 10.1007/s00520-019-05181-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
7 Lewter LA, Golani LK, Cook JM, Li JX. Blockade of α1 subtype GABAA receptors attenuates the development of tolerance to the antinociceptive effects of midazolam in rats. Behav Pharmacol 2021;32:345-50. [PMID: 33290344 DOI: 10.1097/FBP.0000000000000614] [Reference Citation Analysis]
8 Wang T, Niu K, Fan A, Bi N, Tao H, Chen XT, Wang HL. Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depression-like behaviour via cannabinoid system in sleep deprivation rats. Behav Brain Res 2020;384:112545. [PMID: 32035867 DOI: 10.1016/j.bbr.2020.112545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lei H, Wang W, Cao Y, Ma Y, Xue X. Efficacy and safety evaluation of bright light therapy in patients with post-stroke insomnia: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27937. [PMID: 34918641 DOI: 10.1097/MD.0000000000027937] [Reference Citation Analysis]
10 Schreiber S, Pick CG. Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep? Med Hypotheses 2020;136:109501. [PMID: 31759303 DOI: 10.1016/j.mehy.2019.109501] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Wu H, Cao Y, Qu Y, Li T, Wang J, Yang Y, Zhang C, Sun Y. Integrating UPLC-QE-Orbitrap-MS technology and network pharmacological method to reveal the mechanism of Bailemian capsule to relieve insomnia. Nat Prod Res 2021;:1-5. [PMID: 33729065 DOI: 10.1080/14786419.2021.1900176] [Reference Citation Analysis]
12 Guo F, Yi L, Zhang W, Bian ZJ, Zhang YB. Association Between Z Drugs Use and Risk of Cognitive Impairment in Middle-Aged and Older Patients With Chronic Insomnia. Front Hum Neurosci 2021;15:775144. [PMID: 34955792 DOI: 10.3389/fnhum.2021.775144] [Reference Citation Analysis]
13 Scharner V, Hasieber L, Sönnichsen A, Mann E. Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing. BMC Geriatr 2022;22:87. [PMID: 35100976 DOI: 10.1186/s12877-022-02757-6] [Reference Citation Analysis]
14 Boafo A, Greenham S, Sullivan M, Bazaid K, Suntharalingam S, Silbernagel L, Magner K, Robillard R. Medications for sleep disturbance in children and adolescents with depression: a survey of Canadian child and adolescent psychiatrists. Child Adolesc Psychiatry Ment Health 2020;14:10. [PMID: 32175006 DOI: 10.1186/s13034-020-00316-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bhardwaj K, Silva AS, Atanassova M, Sharma R, Nepovimova E, Musilek K, Sharma R, Alghuthaymi MA, Dhanjal DS, Nicoletti M, Sharma B, Upadhyay NK, Cruz-Martins N, Bhardwaj P, Kuča K. Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential. Molecules 2021;26:3005. [PMID: 34070179 DOI: 10.3390/molecules26103005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Schifano F, Chiappini S, Corkery JM, Guirguis A. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. Int J Neuropsychopharmacol 2019;22:270-7. [PMID: 30722037 DOI: 10.1093/ijnp/pyz007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 20.5] [Reference Citation Analysis]
17 Choi Y, Raymer BK. Sleep modulating agents. Bioorg Med Chem Lett 2019;29:2025-33. [PMID: 31307886 DOI: 10.1016/j.bmcl.2019.06.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Popova NK, Kulikov AV, Naumenko VS. Spaceflight and brain plasticity: Spaceflight effects on regional expression of neurotransmitter systems and neurotrophic factors encoding genes. Neurosci Biobehav Rev 2020;119:396-405. [PMID: 33086127 DOI: 10.1016/j.neubiorev.2020.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shen C, Li X, Ma P, Li H, Xiao B, Cai W, Xing X. Nicotinamide mononucleotide (NMN) and NMN-rich product supplementation alleviate p-chlorophenylalanine-induced sleep disorders. Journal of Functional Foods 2022;91:105031. [DOI: 10.1016/j.jff.2022.105031] [Reference Citation Analysis]
20 Bába LI, Kolcsár M, Kun IZ, Ulakcsai Z, Bagaméry F, Szökő É, Tábi T, Gáll Z. Effects of Cariprazine, Aripiprazole, and Olanzapine on Mouse Fibroblast Culture: Changes in Adiponectin Contents in Supernatants, Triglyceride Accumulation, and Peroxisome Proliferator-Activated Receptor-γ Expression. Medicina (Kaunas) 2019;55:E160. [PMID: 31108997 DOI: 10.3390/medicina55050160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gobbi G, Comai S. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep. J Pineal Res 2019;66:e12544. [DOI: 10.1111/jpi.12544] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
22 Merino R, Pérez A, Fierro J, Terré R. Prevalence of medication and off-label medication use in acquired brain injury at a neurorehabilitation hospital. Eur J Clin Pharmacol 2019;75:985-94. [PMID: 30834963 DOI: 10.1007/s00228-019-02651-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Louzada LL, Machado FV, Nóbrega OT, Camargos EF. Zopiclone to treat insomnia in older adults: A systematic review. Eur Neuropsychopharmacol 2021;50:75-92. [PMID: 34023645 DOI: 10.1016/j.euroneuro.2021.04.013] [Reference Citation Analysis]
24 Peng L, Morford KL, Levander XA. Benzodiazepines and Related Sedatives. Med Clin North Am 2022;106:113-29. [PMID: 34823725 DOI: 10.1016/j.mcna.2021.08.012] [Reference Citation Analysis]
25 Herrero Babiloni A, Beetz G, Bruneau A, Martel MO, Cistulli PA, Nixdorf DR, Conway JM, Lavigne GJ. Multitargeting the sleep-pain interaction with pharmacological approaches: A narrative review with suggestions on new avenues of investigation. Sleep Med Rev 2021;59:101459. [PMID: 33601274 DOI: 10.1016/j.smrv.2021.101459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Akinnusi M, El Solh AA. Drug treatment strategies for insomnia in patients with post-traumatic stress disorder. Expert Opin Pharmacother 2019;20:691-9. [PMID: 30794468 DOI: 10.1080/14656566.2019.1574745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
27 Sanchez-Alavez M, Benedict J, Wills DN, Ehlers CL. Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal. Sleep 2019;42:zsz020. [PMID: 30715515 DOI: 10.1093/sleep/zsz020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
28 Comai S, Lopez-canul M, De Gregorio D, Posner A, Ettaoussi M, Guarnieri FC, Gobbi G. Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives. Pharmacological Research 2019;144:343-56. [DOI: 10.1016/j.phrs.2019.04.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
29 Diep C, Tian C, Vachhani K, Won C, Wijeysundera DN, Clarke H, Singh M, Ladha KS. Recent cannabis use and nightly sleep duration in adults: a population analysis of the NHANES from 2005 to 2018. Reg Anesth Pain Med 2022;47:100-4. [PMID: 34873024 DOI: 10.1136/rapm-2021-103161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mäkelä KA, Karhu T, Jurado Acosta A, Vakkuri O, Leppäluoto J, Herzig KH. Plasma Orexin-A Levels Do Not Undergo Circadian Rhythm in Young Healthy Male Subjects. Front Endocrinol (Lausanne) 2018;9:710. [PMID: 30568633 DOI: 10.3389/fendo.2018.00710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
31 Bruni O, Angriman M, Melegari MG, Ferri R. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opinion on Pharmacotherapy 2019;20:2257-71. [DOI: 10.1080/14656566.2019.1674283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Melnikov AY. [Acute insomnia: natural course and correction modalities]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:28-35. [PMID: 31317912 DOI: 10.17116/jnevro201911904228] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Braithwaite I, Bhagavan C, Doppen M, Kung S, Oldfield K, Newton-howes G. Medicinal applications of cannabis/cannabinoids. Current Opinion in Psychology 2021;38:1-10. [DOI: 10.1016/j.copsyc.2020.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Jiang B, He D, Guo Z, Gao Z. Dynamic features of placebo effects addressing persistent insomnia disorder: A meta‐analysis of placebo‐controlled randomized clinical trials. J Sleep Res 2020;29. [DOI: 10.1111/jsr.12997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Rusz CM, Ősz BE, Jîtcă G, Miklos A, Bătrînu MG, Imre S. Off-Label Medication: From a Simple Concept to Complex Practical Aspects. Int J Environ Res Public Health 2021;18:10447. [PMID: 34639747 DOI: 10.3390/ijerph181910447] [Reference Citation Analysis]
36 Sys J, Van Cleynenbreugel S, Deschodt M, Van der Linden L, Tournoy J. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review. Eur J Clin Pharmacol 2020;76:363-81. [DOI: 10.1007/s00228-019-02812-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
37 Akid I, Nesbit S, Nanavati J, Bienvenu OJ, Smith TJ. Prevention of Steroid-Induced Neuropsychiatric Complications With Neuroleptic Drugs: A Review. Am J Hosp Palliat Care 2021;:10499091211034771. [PMID: 34387114 DOI: 10.1177/10499091211034771] [Reference Citation Analysis]
38 Contreras A, Pérez C. Insomnio, en busca del tratamiento ideal: fármacos y medidas no farmacológicas. Revista Médica Clínica Las Condes 2021;32:591-602. [DOI: 10.1016/j.rmclc.2021.09.004] [Reference Citation Analysis]
39 Chitimus DM, Popescu MR, Voiculescu SE, Panaitescu AM, Pavel B, Zagrean L, Zagrean AM. Melatonin's Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease. Biomolecules 2020;10:E1211. [PMID: 32825327 DOI: 10.3390/biom10091211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
40 Vitti-Ruela BV, Dokkedal-Silva V, Morelhão PK, Xavier SD, Tufik S, Andersen ML. Insomnia and Treatment Strategies: Improving Quality of Life in Children with Autism Spectrum Disorder. J Autism Dev Disord 2021;51:2559-60. [PMID: 32949314 DOI: 10.1007/s10803-020-04705-y] [Reference Citation Analysis]
41 Woo J, Yang H, Yoon M, Gadhe CG, Pae AN, Cho S, Lee CJ. 3-Carene, a Phytoncide from Pine Tree Has a Sleep-enhancing Effect by Targeting the GABAA-benzodiazepine Receptors. Exp Neurobiol 2019;28:593-601. [PMID: 31698551 DOI: 10.5607/en.2019.28.5.593] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
42 Shah YD, Stringel V, Pavkovic I, Kothare SV. Doxepin in children and adolescents with symptoms of insomnia: a single-center experience. J Clin Sleep Med 2020;16:743-7. [PMID: 32029069 DOI: 10.5664/jcsm.8338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Wang L, Pan Y, Ye C, Guo L, Luo S, Dai S, Chen N, Wang E. A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults. Neurosci Biobehav Rev 2021;131:489-96. [PMID: 34560134 DOI: 10.1016/j.neubiorev.2021.09.035] [Reference Citation Analysis]
44 Comai S, De Gregorio D, Posa L, Ochoa‐sanchez R, Bedini A, Gobbi G. Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin  MT 2 receptors. J Pineal Res 2020;69. [DOI: 10.1111/jpi.12653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Tang B, Yu Y, Yu F, Fang J, Wang G, Jiang J, Han Q, Shi J, Zhang J. The mechanism study of YZG-331 on sedative and hypnotic effects. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113885] [Reference Citation Analysis]
46 Łątka K, Jończyk J, Bajda M. γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases. International Journal of Biological Macromolecules 2020;158:750-72. [DOI: 10.1016/j.ijbiomac.2020.04.126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
47 Greenwald MK, Moses TEH, Roehrs TA. At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities. Transl Res 2021;234:58-73. [PMID: 33711513 DOI: 10.1016/j.trsl.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel) 2021;14:560. [PMID: 34208284 DOI: 10.3390/ph14060560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Heinemann S, Kasper-Deußen AK, Weiß V, Marx G, Himmel W. [Experiences when handling sleep medicines: Group discussions with nursing students about benzodiazepines and Z-drugs]. Pflege 2021. [PMID: 34854326 DOI: 10.1024/1012-5302/a000853] [Reference Citation Analysis]
50 Roch C, Bergamini G, Steiner MA, Clozel M. Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology (Berl) 2021;238:2693-708. [PMID: 34415378 DOI: 10.1007/s00213-021-05954-0] [Reference Citation Analysis]
51 He D, Jiang B, Guo Z, Mu Q, Mcclure MA. Biphasic feature of placebo response in primary insomnia: pooled analysis of data from randomized controlled clinical trials of orexin receptor antagonists. Sleep 2020;43:zsz238. [PMID: 31593985 DOI: 10.1093/sleep/zsz238] [Reference Citation Analysis]
52 Gobbi G, Comai S. Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep. Front Endocrinol (Lausanne) 2019;10:87. [PMID: 30881340 DOI: 10.3389/fendo.2019.00087] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
53 Qiu ZK, Liu ZT, Pang JL, Wu HB, Liu X, Yang ZM, Li X, Chen JS. A network pharmacology study with molecular docking to investigate the possibility of licorice against posttraumatic stress disorder. Metab Brain Dis 2021;36:1763-77. [PMID: 34417940 DOI: 10.1007/s11011-021-00816-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Woo J, Lee CJ. Sleep-enhancing Effects of Phytoncide Via Behavioral, Electrophysiological, and Molecular Modeling Approaches. Exp Neurobiol 2020;29:120-9. [PMID: 32408402 DOI: 10.5607/en20013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
55 Mi WF, Tabarak S, Wang L, Zhang SZ, Lin X, Du LT, Liu Z, Bao YP, Gao XJ, Zhang WH, Wang XQ, Fan TT, Li LZ, Hao XN, Fu Y, Shi Y, Guo LH, Sun HQ, Liu L, Si TM, Zhang HY, Lu L, Li SX. Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder: evidence from polysomnographic and resting-state functional connectivity analyses. Sleep 2020;43:zsaa092. [PMID: 32406918 DOI: 10.1093/sleep/zsaa092] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Palagini L, Manni R, Aguglia E, Amore M, Brugnoli R, Girardi P, Grassi L, Mencacci C, Plazzi G, Minervino A, Nobili L, Biggio G. Expert Opinions and Consensus Recommendations for the Evaluation and Management of Insomnia in Clinical Practice: Joint Statements of Five Italian Scientific Societies. Front Psychiatry 2020;11:558. [PMID: 32670104 DOI: 10.3389/fpsyt.2020.00558] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
57 Jiang B, He D, Guo Z, Mu Q, Zhang L. Efficacy and placebo response of repetitive transcranial magnetic stimulation for primary insomnia. Sleep Medicine 2019;63:9-13. [DOI: 10.1016/j.sleep.2019.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Bonnet U, McAnally HB. How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z-hypnotic drugs. Hum Psychopharmacol 2021;:e2822. [PMID: 34687489 DOI: 10.1002/hup.2822] [Reference Citation Analysis]
59 Chang CJ, Putukian M, Aerni G, Diamond AB, Hong ES, Ingram YM, Reardon CL, Wolanin AT. Mental Health Issues and Psychological Factors in Athletes: Detection, Management, Effect on Performance, and Prevention: American Medical Society for Sports Medicine Position Statement. Clinical Journal of Sport Medicine 2020;30:e61-87. [DOI: 10.1097/jsm.0000000000000817] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Yoon SK, Okyere BA, Strasser D. Polypharmacy and Rational Prescribing: Changing the Culture of Medicine One Patient at a Time. Curr Phys Med Rehabil Rep 2019;7:141-58. [DOI: 10.1007/s40141-019-00220-z] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
61 Irizarry R, Sosa Gomez A, Miles S, Tamayo Acosta J, Tamam L. Managing Bipolar Disease Complicated with Psychosis in Conjunction with Polypharmacy, Parkinson’s Disease, and Multiple Comorbidities. Case Reports in Psychiatry 2022;2022:1-7. [DOI: 10.1155/2022/3813929] [Reference Citation Analysis]
62 Wang Q, Zhu D, Ping S, Li C, Pang K, Zhu S, Zhang J, Comai S, Sun J. Melatonin recovers sleep phase delayed by MK-801 through the melatonin MT2 receptor- Ca2+ -CaMKII-CREB pathway in the ventrolateral preoptic nucleus. J Pineal Res 2020;69:e12674. [PMID: 32535982 DOI: 10.1111/jpi.12674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Seifert J, Maier HB, Führmann F, Bleich S, Stübner S, Sieberer M, Bernegger X, Greil W, Schüle C, Toto S, Grohmann R, Reinhard MA. Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017. J Neural Transm (Vienna) 2022. [PMID: 35524828 DOI: 10.1007/s00702-022-02504-6] [Reference Citation Analysis]
64 Kim TH, Custodio RJ, Cheong JH, Kim HJ, Jung YS. Sleep Promoting Effect of Luteolin in Mice via Adenosine A1 and A2A Receptors. Biomol Ther (Seoul) 2019;27:584-90. [PMID: 31646844 DOI: 10.4062/biomolther.2019.149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
65 Ito H, Takemura Y, Aoki Y, Hattori M, Horikawa H, Yamazaki M. Analysis of the effects of a tricyclic antidepressant on secondary sleep disturbance induced by chronic pain in a preclinical model. PLoS One 2020;15:e0243325. [PMID: 33270791 DOI: 10.1371/journal.pone.0243325] [Reference Citation Analysis]
66 Peckham AM, Evoy KE, Ochs L, Covvey JR. Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? Subst Abuse 2018;12:1178221818801311. [PMID: 30262984 DOI: 10.1177/1178221818801311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
67 Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry 2021. [PMID: 34819636 DOI: 10.1038/s41380-021-01386-6] [Reference Citation Analysis]
68 Mattei C, Taly A, Soualah Z, Saulais O, Henrion D, Guérineau NC, Verleye M, Legros C. Involvement of the GABAA receptor α subunit in the mode of action of etifoxine. Pharmacol Res 2019;145:104250. [PMID: 31059790 DOI: 10.1016/j.phrs.2019.04.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
69 Xu L, Li X, Zhang Y, Ding M, Sun B, Su G, Zhao Y. The effects of linalool acupoint application therapy on sleep regulation. RSC Adv 2021;11:5896-902. [DOI: 10.1039/d0ra09751a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Jahnsen JA, Widnes SF, Schjøtt J. Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers. Drug Healthc Patient Saf 2021;13:151-7. [PMID: 34321931 DOI: 10.2147/DHPS.S296515] [Reference Citation Analysis]
71 McAnally H, Bonnet U, Kaye AD. Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth. Pain Ther 2020;9:441-52. [PMID: 32737803 DOI: 10.1007/s40122-020-00189-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
72 Clark JW, Daykin H, Metha JA, Allocca G, Hoyer D, Drummond SPA, Jacobson LH. Manipulation of REM sleep via orexin and GABAA receptor modulators differentially affects fear extinction in mice: effect of stable versus disrupted circadian rhythm. Sleep 2021:zsab068. [PMID: 33720375 DOI: 10.1093/sleep/zsab068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Flaxer JM, Heyer A, Francois D. Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly. Am J Geriatr Psychiatry 2021;29:585-603. [PMID: 33218915 DOI: 10.1016/j.jagp.2020.10.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Matsumoto T. Suvorexant improves intractable nocturnal enuresis by altering sleep architecture. BMJ Case Rep 2021;14:e239621. [PMID: 33727289 DOI: 10.1136/bcr-2020-239621] [Reference Citation Analysis]
75 Wickwire EM, Amari DT, Juday TR, Frech F, Gor D, Malhotra M. Incremental health care resource use and costs among adult patients with depression and treated for insomnia with zolpidem, trazodone, or benzodiazepines. Curr Med Res Opin 2022;:1-24. [PMID: 35262444 DOI: 10.1080/03007995.2022.2047537] [Reference Citation Analysis]
76 Kwon M, Wang J, Wilding G, Dickerson SS, Dean GE. Brief Behavioral Treatment for Insomnia: A Meta-Analysis. Behav Sleep Med 2021;:1-21. [PMID: 34632908 DOI: 10.1080/15402002.2021.1982715] [Reference Citation Analysis]
77 Jones BE. Arousal and sleep circuits. Neuropsychopharmacology 2020;45:6-20. [PMID: 31216564 DOI: 10.1038/s41386-019-0444-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
78 Huang H, Wang F, Chen Y, Kong S, Huang Q, Lyu D, Yang W, Wei Z, Qian N, Zhang M, Wu C, Zhao J, Cao L, Wu Z, Peng D, Fang Y, Hong W. Difference in the regulation of biological rhythm symptoms of Major depressive disorder between escitalopram and mirtazapine. J Affect Disord 2022;296:258-64. [PMID: 34624810 DOI: 10.1016/j.jad.2021.09.050] [Reference Citation Analysis]
79 Jiang B, He D, Gao Z. Efficacy and Placebo Response of Multimodal Treatments for Primary Insomnia: A Network Meta-Analysis. Clin Neuropharm 2019;42:197-202. [DOI: 10.1097/wnf.0000000000000369] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Ettcheto M, Olloquequi J, Sánchez-López E, Busquets O, Cano A, Manzine PR, Beas-Zarate C, Castro-Torres RD, García ML, Bulló M, Auladell C, Folch J, Camins A. Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia. Front Aging Neurosci 2019;11:344. [PMID: 31969812 DOI: 10.3389/fnagi.2019.00344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
81 Sun Y, Zhang N, Qu Y, Cao Y, Li J, Yang Y, Yang T, Sun Y. Shuangxia decoction alleviates p-chlorophenylalanine induced insomnia through the modification of serotonergic and immune system. Metab Brain Dis 2020;35:315-25. [DOI: 10.1007/s11011-019-00499-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
82 Chung KH, Lee TY, Chung MH. Roles of sedative-hypnotics in patients with recurrent major depressive disorder: a nationwide population-based 14-year follow-up study in Taiwan. Psychopharmacology (Berl) 2021;238:1553-61. [PMID: 33630108 DOI: 10.1007/s00213-021-05786-y] [Reference Citation Analysis]
83 Wu L, Xiang X, Guo H, Tan H. The effect of non-pharmacological interventions on psychological stress and quality of life of parents of children with retinoblastoma: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e28148. [PMID: 34941063 DOI: 10.1097/MD.0000000000028148] [Reference Citation Analysis]
84 Deng SH, Wang ZZ, Lu HY, Li L, Hu JQ, Zhu XQ, Xie HS, Chen HZ, Zhang M, Ni XJ, Qiu C, Shang DW, Wen YG. A Retrospective Analysis of Steady-State Olanzapine Concentrations in Chinese Patients Using Therapeutic Drug Monitoring: Effects of Valproate and Other Factors. Ther Drug Monit 2020;42:636-42. [PMID: 32039940 DOI: 10.1097/FTD.0000000000000738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]